Amgen: Excellent Buy And Hold For A Volatile Market
Amgen is a leading biopharmaceutical company that develops innovative medicines in areas with significant unmet needs. Read ...
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...
These biotech names aren't facing 'huge concern' from tariffs
Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with ...
pharmaphorum2d
Amgen to acquire deCODE Genetics for US $415 million
Amgen’s acquisition will give the company ... one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. The IMPACCT Real World Evidence Summit is back ...
Pharma stocks survive market rout on tariff exemption, but uncertainty continues
Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...
GEN - Genetic Engineering and Biotechnology News5d
StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.?
With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...
Barchart on MSN2d
These 2 Buy-Rated Dividend Stocks Could Be Next in Line for a Trump Tariff Selloff. Should You Jump Ship Now?
Analysts warn that these tariffs could lead to higher production costs, reduced profitability, and even drug shortages. As Trump’s tariff threats loom, investors are left questioning whether to hold ...
Pharma stocks up on US tariff exemptions but analyst flags a $46B import cost risk
Pharmaceutical (TADAWUL:2070) stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts ...